Optimal Timing of Zoster Vaccine After Zoster Illness
NCT02704572
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Shingles
Interventions
BIOLOGICAL:
Zostavax
Sponsor
Seoul National University Hospital